News
Carbon

CARBON Newsletter (27 May 2025) - Your Latest News About CRISPR in AgroBio

Some of the best links we picked up around the internet

By: Gorm Palmgren - May. 27, 2025
News

CRISPR AgroBio News (CARBON) - an emerging initiative from CRISPR Medicine News - has been hibernating for two years, but now we are back on track again.

CARBON will bring you the latest news on how CRISPR can shape agriculture for the future to guarantee food security in times of population growth and climate change.

To get more CRISPR AgroBio News delivered to your inbox, sign up to the free weekly CARBON Newsletter here.

Top picks

Technical advances

Disease and stress control

Agronomic traits

Industry

Detection

Perspectives

  • A Spotlight in Trends in Biotechnology discusses recent work by Weiss et al. Here, the researcher demonstrated viral delivery of the compact genome editor TnpB into Arabidopsis thaliana, achieving transgene-free heritable modifications that could transform plant biotechnology by enabling field-deployable genome editing as simple as pesticide application.
  • An editorial in Frontiers in Genome Editing highlights CRISPR as a transformative tool for crop improvement, discussing recent advances, including enhanced micronutrient accumulation in rice through OsNAS2 promoter editing and novel CRISPR variants like RNA editing, base editors, and prime editors. The authors emphasise CRISPR's potential to address agricultural challenges whilst acknowledging ongoing obstacles, including regulatory frameworks, intellectual property issues, and technical limitations in polyploid crops and polygenic trait manipulation.
  • An editorial by The African Centre for Technology Studies (ACTS) examines CRISPR-Cas9's application in developing disease-resistant crops, highlighting successful implementations in wheat (TaMLO gene for powdery mildew resistance), rice, soybean, and sweet orange. The authors emphasise CRISPR's advantages over traditional breeding methods, including precision targeting of susceptibility genes, reduced reliance on chemical pesticides, and faster development timelines. The piece particularly focuses on Africa's potential to leverage CRISPR for climate-resilient crops, with ongoing projects including disease-resistant banana, maise resistant to lethal necrosis, and Striga-resistant sorghum to address regional food security challenges.

Reviews

Tags

HashtagArticleHashtagNewsHashtagCARBONHashtagCARBON NewsletterHashtagBayer

CLINICAL TRIALS
Indicator
IND Enabling
Phase I
Phase II
Phase III
Metastatic Melanoma, (NCT06783270)
Sponsors:
Inge Marie Svane
Indicator
IND Enabling
Phase I
Phase II
Phase III
Systemic Lupus Erythematosus, SLE, (NCT06752876)
Sponsors:
Caribou Biosciences, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine